Treatment and quality of life during Prostate Cancer according to Bayer
November is the month dedicated to raising awareness of prostate cancer and men’s health. Every year, around half a million European men are diagnosed with prostate cancer. Still, less than half of the European men (48%) know about prostate cancer and its risks.
According to BAYER, “The development of new treatments means there may be options to choose from that are effective while allowing men to keep doing the things they enjoy. Yet, many men with prostate cancer and their caregivers can often struggle to find their voice in treatment discussions about the things that matter most to them.”
BAYER decorticated this topic in an interview with Robert Greene, Founder & President of HungerNdThirst Foundation and Board Member at the European Cancer Patient Coalition, showcasing his experience as a patient advocate, but also as a prostate cancer patient himself.